Screener
Integra LifeSciences IART Tissue Reconstruction — Intangible asset amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Dollars in thousands | Three Months Ended June 30, 2026 / Specialty Surgery | Three Months Ended June 30, 2026 / Tissue Reconstruction | Three Months Ended June 30, 2026 / Corporate and Other | Three Months Ended June 30, 2026 / Total | Six Months Ended June 30, 2026 / Specialty Surgery | Six Months Ended June 30, 2026 / Tissue Reconstruction | Six Months Ended June 30, 2026 / Corporate and Other | Six Months Ended June 30, 2026 / Total |
|---|---|---|---|---|---|---|---|---|
| Cost of goods sold | 130,212 | 41,989 | 26,816 | 199,017 | 240,687 | 79,448 | 53,818 | 373,953 |
| Research and development | 14,200 | 8,169 | 1,884 | 24,253 | 26,053 | 15,701 | 6,000 | 47,754 |
| Selling, general & administrative | 75,983 | 40,394 | 56,059 | 172,436 | 153,664 | 83,920 | 113,087 | 350,671 |
| Intangible asset amortization | — | — | 3,770 | 3,770 | — | — | 7,546 | 7,546 |
| Total cost and expenses | 220,395 | 90,552 | 88,529 | 399,476 | 420,404 | 179,069 | 180,451 | 779,924 |
| Operating income (loss) | 88,874 | 18,940 | (88,529) | 19,285 | 172,000 | 39,206 | (180,451) | 30,755 |
| Interest income | 4,267 | 8,372 | ||||||
| Interest expense | (22,994) | (45,459) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's tissue reconstruction — intangible asset amortization?
- Integra LifeSciences (IART) reported tissue reconstruction — intangible asset amortization of $0 in Q2 2026.
- What does tissue reconstruction — intangible asset amortization mean?
- This represents the periodic expense recognized for the systematic allocation of the cost of intangible assets, such as patents or acquired technology, within the Tissue Reconstruction segment. It reflects the non-cash cost of maintaining the segment's intellectual property portfolio.
Ask your AI about Integra LifeSciences's tissue reconstruction — intangible asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude